SCHEMBL9012298

SCHEMBL9012298

CCCC(C)OC(=O)C(C)CCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.44
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
CHRM1 P11229 1/20 0.36
AKR1A1 P14550 1/20 0.36
CHRM3 P20309 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
DRD3 P35462 1/20 0.36
SLC6A3 Q01959 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2990052 0.89 FAAH (0.40) FAAHSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL4739524 0.89 FAAH (0.40) FAAHSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL2988148 0.89 FAAH (0.40) FAAHSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL14764032 0.89 FAAH (0.43) FAAHALDH1A1CNR1CNR2CHRM1
SCHEMBL19115181 0.88 FAAH (0.56) FAAHALDH1A1CNR1CNR2FDPS
SCHEMBL7225228 0.86 FAAH (0.63) FAAHALDH1A1CNR1CNR2CA1
SCHEMBL19359773 0.86 FAAH (0.63) FAAHALDH1A1CNR1CNR2CA1
SCHEMBL17878541 0.85 FAAH (0.41) FAAHALDH1A1CNR1CNR2CHRM1
SCHEMBL17860700 0.85 FAAH (0.41) FAAHALDH1A1CNR1CNR2CHRM1
SCHEMBL18270572 0.84 LMNA (0.42) FAAHSMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
EP-3416729-B1 PRO-FRAGRANCE COMPOSITION AQDOT LTD (GB) 2023-09-20 EP disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 US disclosed
EP-3368542-B1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2022-06-22 EP disclosed
CN-108601958-B Pro-fragrance compositions 爱客多有限公司 2022-06-17 CN disclosed
US-11357246-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2022-06-14 US disclosed
CN-108473484-B Compounds useful as TRPM8 modulators 弗门尼舍公司 2021-06-29 CN disclosed
CN-108601958-A Pro-perfume compositions 爱客多有限公司 2018-09-28 CN disclosed
US-5525506-A Process for production of avermectins and cultures therefor PFIZER INC. (US) 1996-06-11 US disclosed
US-5238848-A Cultures for production of avermectins PFIZER INC (US) 1993-08-24 US disclosed
US-5077278-A Parasiticides PFIZER INC. (US) 1991-12-31 US disclosed
EP-0098791-B1 2-METHYLPENTANOIC-ACID ESTERS WITH BRANCHED OR CARBOCYCLIC ALCOHOLS, THEIR PREPARATION AND USE AS PERFUMING AGENTS Henkel Kommanditgesellschaft auf Aktien (DE) 1986-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 FAAH 2804/4885SMN1; SMN2 1778/4885ALDH1A1 978/4885
US-11357246-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 FAAH 2804/4885SMN1; SMN2 1778/4885ALDH1A1 978/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 FAAH 2804/4885SMN1; SMN2 1778/4885ALDH1A1 978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.